Intech Investment Management LLC Black Diamond Therapeutics, Inc. Transaction History
Intech Investment Management LLC
- $9.39 Billion
- Q1 2025
A detailed history of Intech Investment Management LLC transactions in Black Diamond Therapeutics, Inc. stock. As of the latest transaction made, Intech Investment Management LLC holds 29,791 shares of BDTX stock, worth $93,841. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,791
Previous 19,247
54.78%
Holding current value
$93,841
Previous $41,000
12.2%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding BDTX
# of Institutions
96Shares Held
41.3MCall Options Held
45.1KPut Options Held
37K-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.4MShares$32.8 Million0.01% of portfolio
-
Vestal Point Capital, LP New York, NY5.6MShares$17.6 Million0.62% of portfolio
-
Nea Management Company, LLC Timonium, MD4.45MShares$14 Million0.65% of portfolio
-
Black Rock Inc. New York, NY3.22MShares$10.1 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V82.73MShares$8.61 Million0.1% of portfolio
About Black Diamond Therapeutics, Inc.
- Ticker BDTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,339,500
- Market Cap $114M
- Description
- Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...